Search Within

Joseph M Larkin

Formats
  1. Meeting Abstract (5)
  2. Journal Article (3)
Groups
  1. Department of Medicine (6)
  2. Solid Tumor Oncology Division (6)
  3. GDMT, Medicine (5)
  4. Gynecologic Medicine Service (5)
  5. Gynecology Disease Management Team (5)
  6. Nursing (2)

More Groups

People
  1. David Spriggs (5)
  2. Martee Hensley (5)
  3. Carol Aghajanian (3)
  4. Jakob Dupont (3)
  5. Jason Konner (3)
  6. Paul Sabbatini (3)

More People

Years
  1. 2023 (1)
  2. 2012 (1)
  3. 2009 (1)
  4. 2008 (1)
  5. 2007 (1)
  6. 2005 (1)

More Years

Publications
  1. Journal of Clinical Oncology (3)
  2. Clinical Cancer Research (2)
  3. EJC Supplements (1)
  4. Gynecologic Oncology (1)
  5. Investigational New Drugs (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. American Association for Cancer Research (2)
  3. Elsevier Inc. (1)
  4. Pergamon-Elsevier Science Ltd (1)
  5. Springer (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Durable clinical outcomes in patients (pts) with advanced melanoma and progression-free survival (PFS) ≥3y on nivolumab (NIVO) ± ipilimumab (IPI) or IPI in checkmate 067
    Meeting Abstract

    Hodi, F. S.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. J.; Rutkowski, P.; Lao, C. D.; Cowey, C. L.; Schadendorf, D.; Wagstaff, J.; Dummer, R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase 1 study of KOS-862 (Epothilone D) co-administered with carboplatin (Paraplatin®) in patients with advanced solid tumors
    Journal Article

    Monk, J. P.; Villalona-Calero, M.; Larkin, J.; Otterson, G.; Spriggs, D.; Hannah, A. L.; Cropp, G. F.; Johnson, R. G.; Hensley, M. L.
    Investigational New Drugs (2012)

    Fulltext@MSK | Save
  • Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study
    Journal Article

    Hensley, M. L.; Ishill, N.; Soslow, R.; Larkin, J.; Abu Rustum, N.; Sabbatini, P.; Konner, J.; Tew, W.; Spriggs, D.; Aghajanian, C. A.
    Gynecologic Oncology (2009)

    Fulltext@MSK | Save
  • A phase I trial of pemetrexed plus gemcitabine given biweekly with B-vitamin support in solid tumor malignancies or advanced epithelial ovarian cancer
    Journal Article

    Hensley, M. L.; Larkin, J.; Fury, M.; Gerst, S.; Tai, D. F.; Sabbatini, P.; Konner, J.; Orlando, M.; Goss, T. L.; Aghajanian, C. A.
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • Phase I study of pemetrexed (P) plus gemcitabine (G) in advanced solid tumors (ST)
    Meeting Abstract

    Fury, M. G.; Larkin, J.; Gerst, S. R.; Sabbatini, P.; Konner, J.; Orlando, M.; Tai, D. F.; Goss, T.; Aghajanian, C.; Hensley, M. L.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase 1 trial of KOS-862 (epothilone D) in combination with carboplatin (C) in patients with solid tumors
    Meeting Abstract

    Monk, J. P.; Calero-Villalona, M.; Dupont, J.; Larkin, J.; Otterson, G.; Spriggs, D.; Hannah, A. L.; Cropp, G. F.; Johnson, R. G.; Hensley, M. L.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • KOS-862 (Epothilone D): Phase 1 dose escalating and pharmacokinetic (PK) study in patients (pts) with advanced malignancies
    Meeting Abstract

    Spriggs, D. R.; Dupont, J.; Pezzulli, S.; Larkin, J.; Cropp, G.; Zhou, Y.; Sherrill, M.; Johnson, R. Jr; Hannah, A. L.
    EJC Supplements (2003)

    Fulltext@MSK | Save
  • Phase 1 dose escalating and pharmacokinetic (PK) study of KOS-862 (epothilone D): Phase 2 dose and schedule defined
    Meeting Abstract

    Spriggs, D.; Dupont, J.; Pezzulli, S.; Larkin, J.; Cropp, G.; Johnson, R.; Hannah, A. L.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save